Chinese medicine is facing many challenges under the acceleration of "going to sea"

In recent years, Chinese herbal medicines and Chinese herbal decoction pieces have emerged in overseas markets, showing strong development potential
.
According to statistics, in 2020, the import and export volume of Chinese medicine will reach 6.
37 billion U.
S.
dollars, and the export value will be 4.
28 billion U.
S.
dollars, a year-on-year increase of 6.
6%
.
Among them, the export value of plant extracts reached US$2.
44 billion, a year-on-year increase of 3.
6%; the export value of Chinese medicinal materials and decoction pieces was US$1.
31 billion, a year-on-year increase of 15.
2%
.
At the same time, a batch of Chinese medicine companies' products are also speeding up overseas
.
It is understood that the current global sales volume of Lianhua Qingwen Capsules of Yiling Pharmaceutical has exceeded 400 million boxes
.
And as of July 2021, which Lianhuaqingwen capsule also has obtained registration approval or import licenses in 24 countries and regions, including Canada, Russia, Brazil and so on
.
However, it should be noted that although traditional Chinese medicine has the basis for'going out' and has achieved certain results, it also has many drawbacks
.
As a whole, compared with the hot sales of Chinese medicinal materials, the export situation of Chinese patent medicines is still not optimistic
.
In the first half of 2020, the average export prices of Chinese patent medicines to Southeast Asia, North America, and the European Union have maintained double-digit growth, 27.
14%, 34.
24%, and 50.
43% respectively
.
However, proprietary Chinese medicines account for only 9.
3% of the total export value of Chinese medicine products, so they are still in a weak position relative to raw materials
.
In addition, there are still difficulties in overseas registration of Chinese medicine, the lack of comprehensive Chinese medicine registration regulations in various countries is still not recognized, and the lack of professional Chinese medicine doctors and pharmacists
.
Among them, the main problem affecting the development of Chinese medicine overseas markets is that Chinese medicine has so far lacked a unified scientific standard that can be recognized by Western countries
.
Since there is no breakthrough in invention patents in the field of Chinese medicine in China, and the components and functions of Chinese medicine are difficult to scientifically define as Western medicine, the threshold for Chinese medicine to enter the market is very high in foreign countries
.
And it is also facing some problems in the laws and regulations of different countries, cognition of ideas, etc.

.
In addition, foreign countries are also very strict on heavy metals, pesticide residues, and toxicity of Chinese herbal medicines
.
In this regard, the analysis believes that in order for Chinese medicine to go out better, on the one hand, it needs to invest in research on the basic ingredients and side effects of commonly used Chinese medicines to establish standards; on the other hand, it is also important to control the quality of Chinese medicinal materials from the source.

.
On the whole, the industry believes that in order to accelerate the Chinese medicine industry to go overseas, it needs to realize modernization, industrialization, and standardized development through the integration of production, education and research
.
Without industrialization, there will be no development prospects.
Industrialization is the current pain point in the development of Chinese medicine and should be the focus of development
.
As a manufacturing company, it must start from itself and establish a complete and market-recognized technical system and standards in order to allow Chinese medicine to enter foreign markets more reasonably and legally
.
In fact, more and more regions and companies have begun to control the quality of traditional Chinese medicine products from the source
.
Especially after the 2020 version of the "Chinese Pharmacopoeia" is officially implemented, the country's requirements for medicinal plants are becoming more and more stringent
.